EAM
Eventide Asset Management’s Cogent Biosciences COGT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-919,635
| Closed | -$9.93M | – | 209 |
|
|
2024
Q3 | $9.93M | Sell |
919,635
-479,357
| -34% | -$5.18M | 0.17% | 121 |
|
|
2024
Q2 | $11.8M | Buy |
+1,398,992
| New | +$11.8M | 0.2% | 119 |
|
|
2024
Q1 | – | Sell |
-2,232,968
| Closed | -$13.1M | – | 163 |
|
|
2023
Q4 | $13.1M | Buy |
2,232,968
+82,968
| +4% | +$488K | 0.21% | 110 |
|
|
2023
Q3 | $21M | Sell |
2,150,000
-1,290,796
| -38% | -$12.6M | 0.38% | 79 |
|
|
2023
Q2 | $40.7M | Buy |
3,440,796
+851,018
| +33% | +$10.1M | 0.69% | 49 |
|
|
2023
Q1 | $27.9M | Hold |
2,589,778
| – | – | 0.51% | 64 |
|
|
2022
Q4 | $29.9M | Sell |
2,589,778
-271,114
| -9% | -$3.13M | 0.59% | 55 |
|
|
2022
Q3 | $42.7M | Sell |
2,860,892
-2,234,108
| -44% | -$33.3M | 0.84% | 45 |
|
|
2022
Q2 | $46M | Buy |
5,095,000
+1,195,000
| +31% | +$10.8M | 0.98% | 40 |
|
|
2022
Q1 | $29.2M | Buy |
3,900,000
+385,091
| +11% | +$2.88M | 0.46% | 65 |
|
|
2021
Q4 | $30.2M | Buy |
+3,514,909
| New | +$30.2M | 0.39% | 76 |
|